Back to Search
Start Over
Pin1 is required for sustained B cell proliferation upon oncogenic activation of Myc.
- Source :
-
Oncotarget [Oncotarget] 2016 Apr 19; Vol. 7 (16), pp. 21786-98. - Publication Year :
- 2016
-
Abstract
- The c-myc proto-oncogene is activated by translocation in Burkitt's lymphoma and substitutions in codon 58 stabilize the Myc protein or augment its oncogenic potential. In wild-type Myc, phosphorylation of Ser 62 and Thr 58 provides a landing pad for the peptidyl prolyl-isomerase Pin1, which in turn promotes Ser 62 dephosphorylation and Myc degradation. However, the role of Pin1 in Myc-induced lymphomagenesis remains unknown. We show here that genetic ablation of Pin1 reduces lymphomagenesis in Eμ-myc transgenic mice. In both Pin1-deficient B-cells and MEFs, the proliferative response to oncogenic Myc was selectively impaired, with no alterations in Myc-induced apoptosis or mitogen-induced cell cycle entry. This proliferative defect wasn't attributable to alterations in either Ser 62 phosphorylation or Myc-regulated transcription, but instead relied on the activity of the ARF-p53 pathway. Pin1 silencing in lymphomas retarded disease progression in mice, making Pin1 an attractive therapeutic target in Myc-driven tumors.<br />Competing Interests: The Authors declare no competing financial interests.
- Subjects :
- Animals
Cells, Cultured
Embryo, Mammalian cytology
Fibroblasts metabolism
Gene Expression Profiling methods
Lymphoma metabolism
Mice, Inbred C57BL
Mice, Knockout
Mice, Transgenic
NIMA-Interacting Peptidylprolyl Isomerase metabolism
Proto-Oncogene Proteins c-myc metabolism
RNA Interference
B-Lymphocytes metabolism
Cell Proliferation genetics
Lymphoma genetics
NIMA-Interacting Peptidylprolyl Isomerase genetics
Proto-Oncogene Proteins c-myc genetics
Subjects
Details
- Language :
- English
- ISSN :
- 1949-2553
- Volume :
- 7
- Issue :
- 16
- Database :
- MEDLINE
- Journal :
- Oncotarget
- Publication Type :
- Academic Journal
- Accession number :
- 26943576
- Full Text :
- https://doi.org/10.18632/oncotarget.7846